This announcement is a separate document:
兴齐眼药:北京市竞天公诚律师事务所关于沈阳兴齐眼药股份有限公司2021年限制性股票激励计划授予价格及授予数量调整、第三个归属期归属条件成就及部分限制性股票作废相关事项的法律意见书
Xingqi Pharmaceutical: Legal Opinion of Beijing Jingtian Gongcheng Law Firm on matters relating to the adjustment of the price and quantity granted under the 2021 Restricted Stock Incentive Plan of Shenyang Xingqi Pharmaceutical Co., Ltd., the achievement of ownership conditions during the third vesting period, and the abolition of some restricted stocks
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.